Comparative Risk for Angioedema Associated With the Use of Drugs That Target the Renin-Angiotensin-Aldosterone System

Study Questions:

What is the risk for angioedema associated with the use of angiotensin-converting enzyme inhibitors (ACEIs), angiotensin-receptor blockers (ARBs), and the direct renin inhibitor aliskiren?